O&G Cases · Gynaecological oncology — survivorship
Survivorship review — assessment and shared-care station
Assessment and shared-care station on gynaecological cancer survivorship: applying the symptom-driven surveillance principle, working up the swollen leg to exclude recurrence before diagnosing lymphoedema, managing sexual dysfunction and treatment-induced menopause, distinguishing adjustment from clinically significant fear of recurrence with the FORT trial, and producing a written survivorship care plan. Includes assessor key and marking domains.
On this page
Study tools
Target exams
Station brief
Format. Assessment and shared-care station, approximately 12 minutes. You are the gynaecology registrar. The assessor feeds examination findings and results as you go. [1]
Candidate instruction. Take a structured survivorship history, screen for the four late-effect clusters, work up the swollen leg to exclude recurrence, address the sexual dysfunction and menopausal symptoms, recognise clinically significant fear of recurrence, and produce a written survivorship care plan for the shared-care transition. [1]
References4ShowHide
- [1]Salani R, Khanna N, Frimer M, et al. An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol, 2017.PMID 28372871
- [2]Woopen H, Sehouli J, Davis A, et al. GCIG-Consensus guideline for Long-term survivorship in gynecologic Cancer: A position paper from the gynecologic cancer Intergroup (GCIG) symptom benefit committee. Cancer Treat Rev, 2022.PMID 35525106
- [3]Maheu C, Lebel S, Bernstein LJ, et al. Fear of cancer recurrence therapy (FORT): A randomized controlled trial. Health Psychol, 2023.PMID 36862474
- [4]Rizzuto I, Oehler MK, Lalondrelle S, et al. Sexual and Psychosexual Consequences of Treatment for Gynaecological Cancers. Clin Oncol (R Coll Radiol), 2021.PMID 34281725